New

Somatostatin Analogs Market

2021

Somatostatin Analogs Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Indication (Acromegaly, NETs, Others); Type (Octreotide, Lanreotide, Pasireotide) Diseases, Immunological Disorders, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, Others); End User (Medical Device Companies, Biopharmaceutical Companies, Others)

| Report Code: TIPRE00010493 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Somatostatin Analogs Market 2028 Indication, Type Diseases, End User | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Somatostatin analogs are used for the treatment of tumors secreting vasoactive intestinal peptide, carcinoid tumors, glucagonomas, and multiple pituitary adenomas. It is also used to treat acromegaly (a condition where there is over secretion of growth hormone in an adult). Somatostatin is a hormone that is produced by many tissues in the body, principally in the nervous and digestive systems.

MARKET DYNAMICS

The somatostatin analogs market is anticipated to grow due to rising incidences of NETs. However, lack of awareness leading to a high number of undiagnosed people is hampering the market growth. Moreover, increasing research and development activity in the somatostatin analogs market has resulted in the increased usage of already existing drug molecules that are expected to drive the growth of the market in the forecast period.

MARKET SCOPE

The "Somatostatin Analogs Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of somatostatin analogs market with detailed market segmentation by type, and indication. The somatostatin analogs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in somatostatin analogs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The somatostatin analogs market is segmented on the basis of type, and indication. Based on type the market is segmented as octreotide, lanreotide, and pasireotide. On the basis of indication the market is categorized as acromegaly, NETs, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the somatostatin analogs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The somatostatin analogs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting somatostatin analogs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the somatostatin analogs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the somatostatin analogs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from somatostatin analogs market are anticipated to have lucrative growth opportunities in the future with the rising demand for somatostatin analogs in the global market. Below mentioned is the list of few companies engaged in the somatostatin analogs market.

The report also includes the profiles of key players in somatostatin analogs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   Chiasma Inc.
  •   CRINETICS PHARMACEUTICALS
  •   Dauntless Pharmaceuticals
  •   Ipsen Pharma
  •   Midatech Pharma PLC
  •   Novartis AG
  •   Peptron, Inc.
  •   Pfizer Inc.
  •   Sun Pharmaceutical Industries Ltd
  •   Teva Pharmaceuticals Inc


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Somatostatin Analogs Market - By Indication
1.3.2 Somatostatin Analogs Market - By Type
1.3.3 Somatostatin Analogs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. SOMATOSTATIN ANALOGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. SOMATOSTATIN ANALOGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SOMATOSTATIN ANALOGS MARKET - GLOBAL MARKET ANALYSIS
6.1. SOMATOSTATIN ANALOGS - GLOBAL MARKET OVERVIEW
6.2. SOMATOSTATIN ANALOGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SOMATOSTATIN ANALOGS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. ACROMEGALY
7.3.1. Overview
7.3.2. Acromegaly Market Forecast and Analysis
7.4. NETS
7.4.1. Overview
7.4.2. NETs Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. SOMATOSTATIN ANALOGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. OCTREOTIDE
8.3.1. Overview
8.3.2. Octreotide Market Forecast and Analysis
8.4. LANREOTIDE
8.4.1. Overview
8.4.2. Lanreotide Market Forecast and Analysis
8.5. PASIREOTIDE
8.5.1. Overview
8.5.2. Pasireotide Market Forecast and Analysis
9. SOMATOSTATIN ANALOGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Somatostatin Analogs Market Overview
9.1.2 North America Somatostatin Analogs Market Forecasts and Analysis
9.1.3 North America Somatostatin Analogs Market Forecasts and Analysis - By Indication
9.1.4 North America Somatostatin Analogs Market Forecasts and Analysis - By Type
9.1.5 North America Somatostatin Analogs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Somatostatin Analogs Market
9.1.5.1.1 United States Somatostatin Analogs Market by Indication
9.1.5.1.2 United States Somatostatin Analogs Market by Type
9.1.5.2 Canada Somatostatin Analogs Market
9.1.5.2.1 Canada Somatostatin Analogs Market by Indication
9.1.5.2.2 Canada Somatostatin Analogs Market by Type
9.1.5.3 Mexico Somatostatin Analogs Market
9.1.5.3.1 Mexico Somatostatin Analogs Market by Indication
9.1.5.3.2 Mexico Somatostatin Analogs Market by Type
9.2. EUROPE
9.2.1 Europe Somatostatin Analogs Market Overview
9.2.2 Europe Somatostatin Analogs Market Forecasts and Analysis
9.2.3 Europe Somatostatin Analogs Market Forecasts and Analysis - By Indication
9.2.4 Europe Somatostatin Analogs Market Forecasts and Analysis - By Type
9.2.5 Europe Somatostatin Analogs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Somatostatin Analogs Market
9.2.5.1.1 Germany Somatostatin Analogs Market by Indication
9.2.5.1.2 Germany Somatostatin Analogs Market by Type
9.2.5.2 France Somatostatin Analogs Market
9.2.5.2.1 France Somatostatin Analogs Market by Indication
9.2.5.2.2 France Somatostatin Analogs Market by Type
9.2.5.3 Italy Somatostatin Analogs Market
9.2.5.3.1 Italy Somatostatin Analogs Market by Indication
9.2.5.3.2 Italy Somatostatin Analogs Market by Type
9.2.5.4 Spain Somatostatin Analogs Market
9.2.5.4.1 Spain Somatostatin Analogs Market by Indication
9.2.5.4.2 Spain Somatostatin Analogs Market by Type
9.2.5.5 United Kingdom Somatostatin Analogs Market
9.2.5.5.1 United Kingdom Somatostatin Analogs Market by Indication
9.2.5.5.2 United Kingdom Somatostatin Analogs Market by Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Somatostatin Analogs Market Overview
9.3.2 Asia-Pacific Somatostatin Analogs Market Forecasts and Analysis
9.3.3 Asia-Pacific Somatostatin Analogs Market Forecasts and Analysis - By Indication
9.3.4 Asia-Pacific Somatostatin Analogs Market Forecasts and Analysis - By Type
9.3.5 Asia-Pacific Somatostatin Analogs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Somatostatin Analogs Market
9.3.5.1.1 Australia Somatostatin Analogs Market by Indication
9.3.5.1.2 Australia Somatostatin Analogs Market by Type
9.3.5.2 China Somatostatin Analogs Market
9.3.5.2.1 China Somatostatin Analogs Market by Indication
9.3.5.2.2 China Somatostatin Analogs Market by Type
9.3.5.3 India Somatostatin Analogs Market
9.3.5.3.1 India Somatostatin Analogs Market by Indication
9.3.5.3.2 India Somatostatin Analogs Market by Type
9.3.5.4 Japan Somatostatin Analogs Market
9.3.5.4.1 Japan Somatostatin Analogs Market by Indication
9.3.5.4.2 Japan Somatostatin Analogs Market by Type
9.3.5.5 South Korea Somatostatin Analogs Market
9.3.5.5.1 South Korea Somatostatin Analogs Market by Indication
9.3.5.5.2 South Korea Somatostatin Analogs Market by Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Somatostatin Analogs Market Overview
9.4.2 Middle East and Africa Somatostatin Analogs Market Forecasts and Analysis
9.4.3 Middle East and Africa Somatostatin Analogs Market Forecasts and Analysis - By Indication
9.4.4 Middle East and Africa Somatostatin Analogs Market Forecasts and Analysis - By Type
9.4.5 Middle East and Africa Somatostatin Analogs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Somatostatin Analogs Market
9.4.5.1.1 South Africa Somatostatin Analogs Market by Indication
9.4.5.1.2 South Africa Somatostatin Analogs Market by Type
9.4.5.2 Saudi Arabia Somatostatin Analogs Market
9.4.5.2.1 Saudi Arabia Somatostatin Analogs Market by Indication
9.4.5.2.2 Saudi Arabia Somatostatin Analogs Market by Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Somatostatin Analogs Market Overview
9.5.2 South and Central America Somatostatin Analogs Market Forecasts and Analysis
9.5.3 South and Central America Somatostatin Analogs Market Forecasts and Analysis - By Indication
9.5.4 South and Central America Somatostatin Analogs Market Forecasts and Analysis - By Type
9.5.5 South and Central America Somatostatin Analogs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Somatostatin Analogs Market
9.5.5.1.1 Brazil Somatostatin Analogs Market by Indication
9.5.5.1.2 Brazil Somatostatin Analogs Market by Type
9.5.5.2 Argentina Somatostatin Analogs Market
9.5.5.2.1 Argentina Somatostatin Analogs Market by Indication
9.5.5.2.2 Argentina Somatostatin Analogs Market by Type
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SOMATOSTATIN ANALOGS MARKET, KEY COMPANY PROFILES
11.1. CHIASMA INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CRINETICS PHARMACEUTICALS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. DAUNTLESS PHARMACEUTICALS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. IPSEN PHARMA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MIDATECH PHARMA PLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVARTIS AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PEPTRON, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUN PHARMACEUTICAL INDUSTRIES LTD
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICALS INC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Chiasma Inc.
2. CRINETICS PHARMACEUTICALS
3. Dauntless Pharmaceuticals
4. Ipsen Pharma
5. Midatech Pharma PLC
6. Novartis AG
7. Peptron, Inc.
8. Pfizer Inc.
9. Sun Pharmaceutical Industries Ltd
10. Teva Pharmaceuticals Inc
TIPRE00010493
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.